DENTSPLY SIRONA Inc. (NASDAQ:XRAY) SVP Sells $100,154.89 in Stock

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) SVP Lisa Yankie sold 1,903 shares of the stock in a transaction that occurred on Friday, November 19th. The shares were sold at an average price of $52.63, for a total transaction of $100,154.89. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

NASDAQ:XRAY opened at $51.26 on Thursday. The company has a quick ratio of 1.13, a current ratio of 1.60 and a debt-to-equity ratio of 0.38. The company has a market cap of $11.21 billion, a P/E ratio of 26.98, a P/E/G ratio of 0.85 and a beta of 0.88. DENTSPLY SIRONA Inc. has a fifty-two week low of $50.54 and a fifty-two week high of $69.54. The firm’s 50 day moving average is $57.08 and its two-hundred day moving average is $61.36.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 4th. The medical instruments supplier reported $0.68 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.02 billion. DENTSPLY SIRONA had a net margin of 9.85% and a return on equity of 13.05%. DENTSPLY SIRONA’s revenue was up 19.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.67 earnings per share. Research analysts forecast that DENTSPLY SIRONA Inc. will post 2.89 earnings per share for the current fiscal year.

Several hedge funds have recently modified their holdings of the company. Optimal Asset Management Inc. raised its stake in shares of DENTSPLY SIRONA by 0.3% in the 3rd quarter. Optimal Asset Management Inc. now owns 68,883 shares of the medical instruments supplier’s stock valued at $3,999,000 after acquiring an additional 186 shares during the period. Park Avenue Securities LLC raised its stake in shares of DENTSPLY SIRONA by 4.6% in the 3rd quarter. Park Avenue Securities LLC now owns 4,380 shares of the medical instruments supplier’s stock valued at $254,000 after acquiring an additional 194 shares during the period. Boston Private Wealth LLC raised its stake in shares of DENTSPLY SIRONA by 1.0% in the 3rd quarter. Boston Private Wealth LLC now owns 20,873 shares of the medical instruments supplier’s stock valued at $1,212,000 after acquiring an additional 211 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. raised its stake in shares of DENTSPLY SIRONA by 4.2% in the 2nd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 5,256 shares of the medical instruments supplier’s stock valued at $332,000 after acquiring an additional 212 shares during the period. Finally, Headinvest LLC raised its stake in shares of DENTSPLY SIRONA by 0.4% in the 3rd quarter. Headinvest LLC now owns 61,365 shares of the medical instruments supplier’s stock valued at $3,562,000 after acquiring an additional 216 shares during the period. 93.46% of the stock is currently owned by institutional investors and hedge funds.

XRAY has been the topic of a number of analyst reports. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $68.00 target price on the stock in a research report on Thursday, July 29th. Barrington Research raised their target price on shares of DENTSPLY SIRONA from $77.00 to $79.00 and gave the stock an “outperform” rating in a research report on Friday, August 6th. TheStreet upgraded shares of DENTSPLY SIRONA from a “c+” rating to a “b” rating in a research report on Thursday, August 5th. Finally, HC Wainwright decreased their target price on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “neutral” rating on the stock in a research report on Monday, August 9th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus target price of $67.57.

About DENTSPLY SIRONA

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.

Featured Article: Calculate Your Return on Investment (ROI)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.